Efficacy and safety of insulin glargine 300 U/mL in people with type 2 diabetes uncontrolled on basal insulin: the 26-week interventional, single-arm ARTEMIS-DM study
mediaposted on 2022-06-01, 16:12 authored by Bipin Sethi, Khalid Al-Rubeaan, Mustafa Unubol, Maria A Mabunay, Baptiste Berthou, Valerie Pilorget, Shireene R Vethakkan, Gustavo Frechtel
The article associated with this page has been accepted for online publication and is in the final stages of production. The link to the full text will be made available on this page in the next few days. In the meantime, a pre-typeset version of the article is attached. This is not the final publication and may be subject to some minor changes.